Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Inhaled Human Insulin vs Insulin Aspart in Type 1 Diabetes
NCT00725036Phase 3Completed
- Sponsor
- Novo Nordisk
- Start
- Sep 2002
- Primary completion
- Dec 2004
- Modality
- Biologic
- Countries
- 1
01
Overview
A Phase 3 trial of insulin human in type 1 diabetes mellitus (T1D), sponsored by Novo Nordisk. Started Sep 2002; status: completed.
02
Drugs
insulin human
03
Conditions
type 1 diabetes mellitus (T1D)
Beyond the preview
Go deeper on NCT00725036.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00725036.